This article needs additional citations for verification .(November 2019) |
![]() | |
Formerly | Lion Biotechnologies, Inc. |
---|---|
Company type | Public |
| |
Industry | |
Founded | 2007 |
Headquarters | San Carlos, California, U.S. |
Key people | Steven Rosenberg |
Number of employees | 319 (December 31, 2021) |
Website | iovance |
Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte (TIL) therapies against cancer. [1] [2]
The company was founded in 2007 as Genesis Biopharma. In 2013, Lion merged with Genesis Biopharma аnd became lion bio Pharma, which was then rebranded to Iovance in 2017. [3]
In 2024, the US FDA gave accelerated approval to Lifileucel, the company's tumor-infiltrating lymphocyte drug for the treatment of unresectable or metastatic melanoma. [4]